Ground Zero Pharmaceuticals

IRVINE, California, October 5, 2010 - GZP is pleased to announce that it has expanded its capabilities for strategic regulatory and product development support of gene therapy and somatic cell therapies, including treatment vaccines for cancer and other serious or life-threatening diseases.